Virtus ETF Advisers’s Seres Therapeutics MCRB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-808
| Closed | -$38.5K | – | 451 |
|
|
2023
Q3 | $38.5K | Sell |
808
-80
| -9% | -$3.81K | 0.02% | 422 |
|
|
2023
Q2 | $85.1K | Buy |
888
+71
| +9% | +$6.81K | 0.05% | 423 |
|
|
2023
Q1 | $92.7K | Sell |
817
-314
| -28% | -$35.6K | 0.05% | 354 |
|
|
2022
Q4 | $127K | Sell |
1,131
-804
| -42% | -$90.1K | 0.07% | 399 |
|
|
2022
Q3 | $248K | Buy |
1,935
+15
| +0.8% | +$1.92K | 0.1% | 290 |
|
|
2022
Q2 | $132K | Buy |
1,920
+958
| +100% | +$65.9K | 0.05% | 345 |
|
|
2022
Q1 | $137K | Sell |
962
-57
| -6% | -$8.12K | 0.06% | 242 |
|
|
2021
Q4 | $170K | Buy |
1,019
+504
| +98% | +$84.1K | 0.06% | 284 |
|
|
2021
Q3 | $72K | Sell |
515
-26
| -5% | -$3.64K | 0.03% | 391 |
|
|
2021
Q2 | $258K | Sell |
541
-64
| -11% | -$30.5K | 0.11% | 207 |
|
|
2021
Q1 | $249K | Buy |
605
+10
| +2% | +$4.12K | 0.11% | 289 |
|
|
2020
Q4 | $291K | Buy |
+595
| New | +$291K | 0.12% | 226 |
|
|
2018
Q2 | – | Sell |
-3,836
| Closed | -$563K | – | 270 |
|
|
2018
Q1 | $563K | Buy |
3,836
+2,071
| +117% | +$304K | 0.49% | 107 |
|
|
2017
Q4 | $358K | Buy |
1,765
+151
| +9% | +$30.6K | 0.45% | 79 |
|
|
2017
Q3 | $518K | Buy |
1,614
+148
| +10% | +$47.5K | 0.07% | 87 |
|
|
2017
Q2 | $331K | Sell |
1,466
-91
| -6% | -$20.5K | 0.05% | 98 |
|
|
2017
Q1 | $351K | Buy |
1,557
+150
| +11% | +$33.8K | 0.06% | 123 |
|
|
2016
Q4 | $279K | Buy |
1,407
+1,002
| +247% | +$199K | 0.08% | 115 |
|
|
2016
Q3 | $100K | Hold |
405
| – | – | 0.05% | 150 |
|
|
2016
Q2 | $235K | Buy |
405
+76
| +23% | +$44.1K | 0.17% | 109 |
|
|
2016
Q1 | $175K | Buy |
+329
| New | +$175K | 0.24% | 106 |
|